
CRDN and RareKids-CAN co-host pre-clinical therapy development workshop
CRDN joined leaders from across Canada at the RareKids-CAN Conference and co-hosted a mini workshop on pre-clinical therapy development.
News related to rare disease, including patient stories, new programs and initiatives, and more.

CRDN joined leaders from across Canada at the RareKids-CAN Conference and co-hosted a mini workshop on pre-clinical therapy development.
SickKids research provides a genetic diagnosis to more families experiencing rare intestinal disorders.
McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million to support three pioneering RNA-based research projects aimed at advancing therapies for rare genetic diseases and cancers.

The Government of Canada and Québec have announced a $305 million agreement to improve access to new and existing drugs, support early diagnosis and screening, and advance Québec’s Action Plan on Rare Diseases 2023-2027.

The Honourable Mark Holland, Canada’s Minister of Health, and the Honourable John Main, Nunavut’s Minister of Health, announced a bilateral agreement investing over $7.3 million over three years to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.

The Honourable Mark Holland, Canada’s Minister of Health, and the Honourable Lesa Semmler, Northwest Territories’ Minister of Health and Social Services, announced a bilateral agreement investing over $7.8 million to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.
Stay updated with the latest developments and events from the CRDN as we advance rare disease research and care across Canada.